Lexicon Pharmaceuticals, Inc.
LXRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $49.8M | $31.1M | +60.2% |
| Operating income | −$48.9M | −$197M | +75.2% |
| Net income | −$50.3M | −$200M | +74.9% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $11.2M | $14.2M | −21.1% |
| Operating income | −$14.5M | −$12.2M | −18.9% |
| Net income | −$14.0M | −$12.8M | −9.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Lexicon's revenue in FY2025?
- $49.8M in FY2025 (Fiscal year ended Dec 31, 2025), +60.2% vs $31.1M a year earlier, per its 10-K filed Mar 2026.
- Was Lexicon profitable in FY2025?
- No: net income was −$50.3M and operating income −$48.9M in FY2025.
- What was Lexicon's revenue in Q3 2026?
- $11.2M (−21.1% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.